RCC2 and breast carcinoma: Moreover, RCC2 plays an oncogenic role in breast cancer, by activating Wnt-signaling pathway, thus promoting cell proliferation and migration through Epithelial-mesenchymal transition (EMT) (Chen et al., 2019).